作者
Giuseppe Curigliano, Susana Banerjee, Andrés Cervantes, Marina C Garassino, Pilar Garrido, Nicolas Girard, John Haanen, Karin Jordan, Florian Lordick, Jean-Pascal Machiels, Olivier Michielin, Solange Peters, Josep Tabernero, Jean-Yves Douillard, George Pentheroudakis, A Addeo, L Albiges, PA Ascierto, F Barlesi, C Caldas, F Cardoso, IF Chaberny, NI Cherny, TK Choueiri, MLK Chua, C Criscitiello, E de Azambuja, D De Ruysscher, E de Vries, R Dent, Domenico D’Ugo, R Dziadziuszko, C Faivre-Finn, E Felip, M Garassino, R Glynne-Jones, V Golfinopoulos, E Hamilton, PA Jänne, R Kanesvaran, SB Kim, UG Liebert, TSK Mok, G Morgan, R Obermannova, K Park, A Passaro, M Reck, R Salazar Soler, F Scotté, S Senan, C Sessa, E Smyth, R Soo, JC Soria, J Spicer, F Strasser, DSW Tan, D Trapani, E Van Cutsem, H van Halteren, PE van Schil, G Veronesi, J Yang
发表日期
2020/10/1
期刊
Annals of Oncology
卷号
31
期号
10
页码范围
1320-1335
出版商
Elsevier
简介
We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 …
引用总数
201920202021202220232024114119966914
学术搜索中的文章